Bsf Enterprise Plc · LSE:BSFA

Bsf Enterprise — Investor Presentation (December 2025)

18 slides from Bsf Enterprise's investor presentation, December 2025

1. Slide 1: Unlocking the next generation of tissue engineered materials

   LON: BSFA (UK) | BSFAF: QB (US) Unlocking the next generation of tissue engineered materials INVESTOR PRESENTATION December 2025 1 © 2025 BSF Enterprise PLC. All rights reserved.

2. Slide 2: Executive Summary

   LON: BSFA (UK) | BSFAF: QB (US) Executive Summary • BSF Enterprise PLC believes that sustainability is at the core of future biotechnological processes and products. • By supporting the development of in-house and acquired technologies our subsidiary companies create valuable and world leading produ

3. Slide 3: BSF Enterprise PLC – Management Team

   LON: BSFA (UK) | BSFAF: QB (US) BSF Enterprise PLC – Management Team Dr. Che Connon Geoffrey Baker Graham Duncan Ricardo Gouveia Marcelo Bravo Managing Director Executive Director CFO CSO CBO o Internationally o A qualified lawyer in o A Chartered o Scientist with expertise o Seasoned entrepreneur ack

4. Slide 4: Biotech that addresses real challenges

   Biotech that addresses real challenges. • Livestock farming causes 24% of greenhouse gas emissions, uses 33% of drinking water, and 66% of antibiotics. • It leads to more deforestation than soy, palm oil, and wood combined. • Tissue engineered cultured alternatives can eliminate the slaughter of 70

5. Slide 5: Multiple Growth Opportunities

   LON: BSFA (UK) | BSFAF: QB (US) Multiple Growth Opportunities Lab-Grown Cultivated Meat 3D Bio-Tissues Leather Technologies 5 © 2025 BSF Enterprise PLC. All rights reserved.

6. Slide 6: Lab-Grown Leather Ltd

   LON: BSFA (UK) | BSFAF: QB (US) Lab-Grown Leather Ltd LGL is applying (under licence) 3DBT’s patented advanced tissue engineering platform (ATEP™) to create leather alternatives (Elemental Leather™) for high-value markets, including luxury goods, sportsware, aerospace, and automotive. Three core pro

7. Slide 7: The leather industry's foundation is unsustainable

   LON: BSFA (UK) | BSFAF: QB (US) The leather industry’s foundation is unsustainable 7 © 2025 BSF Enterprise PLC. All rights reserved.

8. Slide 8: Today's alternatives force a compromise

   LON: BSFA (UK) | BSFAF: QB (US) Today’s alternatives force a compromise 8 © 2025 BSF Enterprise PLC. All rights reserved.

9. Slide 9: Our ATEP Platform: Teaching cells to build perfect leather

   LON: BSFA (UK) | BSFAF: QB (US) Our ATEPTM Platform: Teaching cells to build perfect leather 9 © 2025 BSF Enterprise PLC. All rights reserved.

10. Slide 10: We didn't just replicate leather. We unleashed its potential

    LON: BSFA (UK) | BSFAF: QB (US) We didn’t just replicate leather. We unleashed its potential 10 © 2025 BSF Enterprise PLC. All rights reserved.

11. Slide 11: Case Study: 3DBT Skin

    LON: BSFA (UK) | BSFAF: QB (US) Case Study: 3DBT Skin Real Leather Without The Animal We are the only company in the world able to make real leather without additives (‘scaffolds’) 11 © 2025 BSF Enterprise PLC. All rights reserved.

12. Slide 12: The Opportunity: A $130B+ Market Ripe for Disruption

    LON: BSFA (UK) | BSFAF: QB (US) The Opportunity: A $130B+ Market Ripe for Disruption 600% Increase in US vegans (2014-24). A clear rise in ethical consumerism Funds secured Investment in place to enable first commercial products 80-90% Expected decrease in lab-based materials costs by 2030 due to ad

13. Slide 13: Kerato Ltd

    LON: BSFA (UK) | BSFAF: QB (US) Kerato Ltd • Kerato leverages advances in tissue engineering to address the global shortage of donor human corneas for medical and research uses with over 13 million people awaiting a corneal Protein Chicken Beef Pork transplant. • The global corneal transplant market

14. Slide 14: 3D Bio-Tissues Ltd

    LON: BSFA (UK) | BSFAF: QB (US) 3D Bio-Tissues Ltd • 3DBT’S R&D has generated leading IP in the growth of cells and production of cultivated tissues such as muscle, cornea and skin • 3DBT’s cell and tissue growth enhancing media additives are used across multiple biotech sectors ○ City-Mix™ provides

15. Slide 15: Next 18 Months: Multiple Value Inflection Points

    LON: BSFA (UK) | BSFAF: QB (US) Next 18 Months: Multiple Value Inflection Points BSF Enterprise is committing significant investment to its subsidiary companies to accelerate growth Lab-Grown leather Ltd Commercial launch of Elemental X™, a proprietary platform unlocking new frontiers in bio-based mat

16. Slide 16: Presentation Disclaimer

    Presentation Disclaimer. The information contained in these slides and communicated orally to you, including the speech(es) of the presenter(s) and any materials distributed at or in connection therewith (together, the “Presentation”) is confidential. By reading the information contained in this Pres

17. Slide 17: Presentation Disclaimer (continued)

    Presentation Disclaimer (continued). The Presentation has not been approved by the FCA and does not constitute, or form part of, an admission document, listing particulars, a prospectus or a circular relating to the Company, nor does it constitute, or form part of, any offer or invitation to sell or

18. Slide 18: www.bsfenterprise.com

    LON:BSFA (UK) BSFAF:QB (US) www.bsfenterprise.com 18 © 2025 BSF Enterprise PLC. All rights reserved.

BSF Enterprise — Investor Presentation (December 2025) on 6ix